How to Apply to Fresenius SE

22 min read Last updated April 20, 2026 4 open positions

Key Takeaways

  • Fresenius SE & Co. KGaA is a DAX 40 German healthcare group (ETR:FRE) headquartered in Bad Homburg vor der Höhe with roughly 191,000 employees and approximately EUR 21 billion of annual continuing-operations revenue, controlled by the Else Kröner-Fresenius-Stiftung charitable foundation.
  • The group operates two focus businesses in 2026: Fresenius Kabi (IV drugs, clinical nutrition, biosimilars, plasma-derived therapeutics, specialty medical devices) and Fresenius Helios (approximately 87 German hospitals under Helios Kliniken plus approximately 57 Spanish hospitals and a large outpatient footprint under Quirónsalud). Fresenius Medical Care was reclassified to equity-method accounting in 2023 and Fresenius Vamed has been substantially wound down under the Fresenius 2025 simplification programme.
  • CEO Michael Sen, in post since 1 October 2022, leads the Fresenius 2025 strategy focused on simplification, margin recovery at Kabi, organic growth at Helios, and disciplined debt reduction. Candidates should engage credibly with this strategic context in interviews.
  • All hiring runs through SAP SuccessFactors Recruiting. Fresenius SE corporate and Kabi globally use careers.fresenius.com; Helios Germany uses helios-gesundheit.de/karriere; Quirónsalud uses quironsalud.es/trabaja-con-nosotros. These are distinct tenants and distinct candidate experiences despite the shared underlying ATS.
  • German is a structural requirement for Helios Germany clinical and administrative roles and for most Bad Homburg corporate roles. English is the primary working language for Kabi international commercial, regulatory, biopharma R&D, and IT roles, and for Fresenius SE group finance and investor relations. Spanish (and sometimes Catalan) is required for Quirónsalud clinical and administrative roles.
  • Clinical roles at Helios Germany require Approbation and Facharzt credentials recognised by the relevant Landesärztekammer; foreign-qualified physicians and nurses must complete the Anerkennung process with the state authority before starting. Fresenius can sponsor EU Blue Cards for specialist and shortage-list roles but sponsorship is case-by-case, not automatic.
  • Compensation follows German healthcare and pharma benchmarks: mid-career nurses typically EUR 45,000 to EUR 70,000, senior physicians EUR 90,000 to EUR 150,000 and above at Chefarzt level, corporate mid-level roles EUR 70,000 to EUR 130,000, executive roles EUR 130,000 to EUR 250,000 plus variable and long-term incentive plans in Fresenius SE shares. Helios clinical pay is anchored by collective bargaining agreements (Marburger Bund for physicians and relevant nursing Tarifverträge).
  • The ownership structure (Else Kröner-Fresenius-Stiftung as controlling general partner of a KGaA) shapes a long-term, stakeholder-oriented culture rather than a quarterly-earnings-driven one. Candidates who understand and value this governance context tend to thrive at Fresenius.

About Fresenius SE

Fresenius SE & Co. KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, a commuter town about 15 kilometres north of Frankfurt am Main in the German state of Hesse. The firm is constituted as a Societas Europaea (SE) operating in the legal form of a Kommanditgesellschaft auf Aktien (KGaA), a partnership limited by shares under German law, with the Else Kröner-Fresenius-Stiftung (a charitable foundation established under the will of former chairwoman Else Kröner) as the controlling general partner. Fresenius employs roughly 191,000 people worldwide, reports approximately EUR 21 billion of annual revenue in its current continuing-operations perimeter, and is listed on the Frankfurt Stock Exchange (Deutsche Börse) as a constituent of the DAX 40 under the ticker ETR:FRE. The firm traces its roots to the 18th-century Hirsch Apotheke in Frankfurt and was rebuilt in the 20th century by Else Kröner into a specialist dialysis and infusion business, then expanded through four decades of acquisitions into the integrated healthcare group it is today. The group's shape in 2026 is materially different from the one that existed in 2022. Under Chief Executive Officer Michael Sen, who took over as CEO on 1 October 2022 after a spell at Siemens Healthineers and Siemens Energy, Fresenius launched the 'Fresenius 2025' strategic plan to simplify the portfolio, restore profitability, pay down debt, and focus the group on two operating businesses: Fresenius Kabi (pharmaceuticals and clinical nutrition) and Fresenius Helios (private hospital operator). As part of that plan, Fresenius Medical Care AG, the dialysis business that had historically been the group's largest subsidiary, was reclassified from full consolidation to the equity method in the 2023 financial statements following a change in its legal form from KGaA to AG that reduced Fresenius SE's ability to control its operations. FMC remains a separately listed DAX-constituent company (ETR:FME) in which Fresenius SE continues to hold a significant minority shareholding, but it is no longer consolidated line-by-line into Fresenius SE group revenue. Fresenius Vamed, the health-facility engineering and services business, has been wound down and partially divested under the same simplification programme, with the remaining hospital-operations activities of Vamed being absorbed into Helios and the project business being exited. That leaves two operating segments driving continuing operations. Fresenius Kabi is a global specialty pharmaceuticals and medical-nutrition business with manufacturing sites and commercial operations across more than 100 countries. Its product portfolio spans intravenous generics (injectable oncology, anaesthesia, anti-infectives, critical care), clinical nutrition (enteral and parenteral nutrition products and compounding services), medical devices for drug delivery and infusion therapy, and a growing biopharmaceuticals franchise centred on biosimilars (the oncology biosimilar Stimufend and the autoimmune-disease biosimilar Tyenne are two prominent examples), cell-and-gene therapy manufacturing services, and plasma-derived therapeutics. Kabi's primary peer set includes Baxter International, B. Braun Melsungen, Hospira-Pfizer injectables, Nipro Corporation, Otsuka, and (in biosimilars specifically) Sandoz, Celltrion, and Samsung Bioepis. Fresenius Helios is the largest private hospital operator in Europe, running approximately 87 hospitals in Germany under the Helios Kliniken brand (branded Helios Gesundheit) and approximately 57 hospitals in Spain plus a large outpatient and diagnostics footprint under the Quirónsalud brand. Helios Germany is regulated by the Gemeinsamer Bundesausschuss (G-BA) and operates within the German statutory health insurance framework (Gesetzliche Krankenversicherung), the state-level Krankenhausplan hospital planning system, and the DRG (Diagnosis-Related Group) reimbursement regime; Quirónsalud in Spain operates under the Spanish Sistema Nacional de Salud and Seguridad Social framework alongside private and insurer-pay channels. Helios's primary German peers are Sana Kliniken, Asklepios Kliniken, Rhön-Klinikum (now substantially absorbed into Asklepios), and the various university and municipal hospital networks; in Spain, Quirónsalud competes with HM Hospitales, Vithas, Ribera Salud, and Sanitas (Bupa). Joining Fresenius SE in 2026 therefore means joining a simplified, still-very-large German healthcare group mid-way through a multi-year restructuring and refocusing programme. The group stated at its 2024 and 2025 capital markets communications that it is targeting structurally higher operating margins at Kabi, continued organic growth at Helios, a strengthened balance sheet, and a disciplined capital-allocation stance with debt reduction as a priority. Candidates should understand that Fresenius 2025 is a real operating programme with genuine cost discipline attached; it is not a brand exercise. The parent-company corporate centre in Bad Homburg has been deliberately slimmed. The group operating language is German for domestic roles and English for international coordination, with Kabi's biopharmaceutical and international commercial organisations running predominantly in English and Helios Germany running predominantly in German for clinical and administrative staff. Candidates should verify the current leadership line-up on fresenius.com before any senior interview, as the Management Board composition has evolved under the Sen programme.

Application Process

  1. 1
    Identify which Fresenius business you are applying into before you apply

    Identify which Fresenius business you are applying into before you apply. Fresenius SE (the holding company in Bad Homburg with corporate functions: finance, treasury, legal, communications, investor relations, group strategy, group HR), Fresenius Kabi (pharmaceuticals and clinical nutrition with manufacturing sites globally and an R&D and biopharma footprint centred on Germany, Austria, the US, and India), Fresenius Helios Germany (Helios Kliniken, clinical and hospital-administration roles across roughly 87 German hospitals), and Quirónsalud in Spain all hire through the same SAP SuccessFactors backend but operate as distinct businesses with different leadership chains, collective bargaining environments, and compensation conventions. The job posting will name the segment and the site; take the segment seriously because the hiring rhythm and criteria differ.

  2. 2
    Start at the canonical careers portals

    Start at the canonical careers portals. The group entry point is careers.fresenius.com, which is the SAP SuccessFactors Career Site tenant covering Fresenius SE corporate, Fresenius Kabi, and central Fresenius group functions globally. Helios Germany maintains its own branded clinical careers portal at helios-gesundheit.de/karriere that surfaces roughly 30,000 open clinical and administrative positions across the German hospital estate. Quirónsalud maintains its Spanish-language careers portal at quironsalud.es/trabaja-con-nosotros. All three portals ultimately use SAP SuccessFactors Recruiting as the ATS backend, but they are distinct candidate-facing experiences, and you will generally need a separate profile for each unless your role sits clearly inside the fresenius.com tenant.

  3. 3
    Create an SAP SuccessFactors candidate profile carefully and reuse it across Fre

    Create an SAP SuccessFactors candidate profile carefully and reuse it across Fresenius SE and Fresenius Kabi roles globally. Upload an ATS-readable PDF or Word CV, then manually correct the parsed Berufserfahrung (work experience), Ausbildung (education), Fähigkeiten (skills), Sprachen (languages), and Zertifikate (certifications) fields. German Lebenslauf conventions (reverse-chronological, with Abitur and Schulabschluss explicitly listed) are standard for domestic roles. For clinical Helios positions, the parsed fields must include Approbation number, Facharzt title and specialty date, Pflegeexamen or Krankenpflegeausbildung dates, and professional register details (Landesärztekammer membership for physicians, Pflegekammer membership where applicable, Apothekerkammer membership for pharmacists).

  4. 4
    Be explicit about language

    Be explicit about language. German is a structural requirement for substantially all Helios Germany clinical roles (physician, nurse, therapist, MTA, pharmacist, ward clerk), for nearly all Helios Germany hospital-administration roles, and for most Fresenius SE corporate roles based in Bad Homburg where German is the day-to-day working language. For Fresenius Kabi international commercial, regulatory, biopharma R&D, and IT roles, and for Fresenius SE group finance and investor-relations roles, English is the primary working language and German is a nice-to-have rather than a hard requirement. Quirónsalud clinical and administrative roles in Spain require Spanish; some Barcelona and Catalonia roles also require Catalan.

  5. 5
    Submit complete documents on the first attempt

    Submit complete documents on the first attempt. German applications typically expect a Lebenslauf (CV, usually two pages), a short Anschreiben (cover letter, one page, addressed to a named person if identifiable), copies of relevant Zeugnisse (degree certificates, Facharzt certificate, Approbation, Ausbildung completion documents), and the most recent Arbeitszeugnis (employer reference letter) from your current or previous employer. Skipping the Zeugnisse or Arbeitszeugnis on a German clinical or corporate application reads as unprofessional and is sometimes enough to be screened out at first sift.

  6. 6
    Expect a recruiter screen within 10 to 20 working days for shortlisted CVs

    Expect a recruiter screen within 10 to 20 working days for shortlisted CVs. The first conversation is typically a 30-minute call with an internal Fresenius recruiter on Microsoft Teams, which confirms motivation, salary expectations in euros, notice period (the German Kündigungsfrist is statutory and scales with tenure; 3 months to the end of a quarter is common at mid and senior level), right-to-work and visa status under EU Blue Card or national residence permit rules, language level, and professional registration status for clinical staff. Fresenius recruiters are thorough rather than quick and default to asking for formal documents early.

  7. 7
    Prepare for two to four rounds of substantive interviews

    Prepare for two to four rounds of substantive interviews. Corporate and Kabi commercial roles typically involve a hiring-manager competency interview, a technical or case interview with a business lead, and a final round with a department head or Management Board member for senior roles. Kabi manufacturing, regulatory, quality, and R&D roles include technical deep-dives aligned to the pharma quality system (EU GMP, FDA cGMP, ICH guidelines, EU MDR and IVDR for medical-device-adjacent products). Helios clinical roles include a Chefarzt or Oberarzt interview covering clinical judgement, teaching capacity, research output, and fit with the department (Klinik), followed by an administrative interview with hospital-management HR. Final in-person rounds are typically held at Bad Homburg (Else-Kröner-Straße 1), at Kabi's Bad Homburg or Friedberg sites, at individual Helios hospitals, or at Quirónsalud head office in Madrid.

  8. 8
    If you are applying to a German apprenticeship (Ausbildung) or dual-study (duale

    If you are applying to a German apprenticeship (Ausbildung) or dual-study (duales Studium) route, target the annual application window in the autumn of the year before you intend to start. Fresenius Kabi runs several Ausbildung tracks including Pharmakant (pharmaceutical process operator), Chemielaborant (chemistry lab technician), Industriekaufmann/-frau (industrial business clerk), and Fachinformatiker (IT specialist), typically aligned to the Industrie- und Handelskammer (IHK) curricula with three-year durations. Helios Germany runs Ausbildung tracks across Pflegefachfrau/-mann (nursing), Medizinische Fachangestellte (MFA), Anästhesietechnische Assistenz (ATA), Operationstechnische Assistenz (OTA), and Notfallsanitäter (paramedic). Dual-study partnerships with Duale Hochschulen (DHBW, IU, FOM and similar) cover business, nursing management, and technical fields. Applications generally open a year ahead of the start date.

  9. 9
    Negotiate based on German healthcare and pharma benchmarks, not Wall Street or U

    Negotiate based on German healthcare and pharma benchmarks, not Wall Street or US tech. Fresenius SE corporate and Kabi offers typically include a base salary, a short-term variable bonus, a share-based long-term incentive plan for leadership roles (denominated in Fresenius SE shares, ETR:FRE), a company-funded betriebliche Altersvorsorge (occupational pension), a Jobticket or Deutschlandticket for public transport, strong Elternzeit (parental leave) beyond the statutory minimum, and 28 to 30 days of annual leave plus German public holidays. Helios Germany clinical pay is anchored by the Marburger Bund physicians' collective agreement (Tarifvertrag) and the nursing collective agreements (TVöD-K equivalents in some cases), so there is less direct negotiation on base pay at junior and mid levels; non-tariff positions (Chefarzt, Geschäftsführer, senior specialists) are individually negotiated.

  10. 10
    Plan for the German employment-onboarding documentation set

    Plan for the German employment-onboarding documentation set. Fresenius runs a standard pre-employment documentation pipeline: Ausweiskopie (ID or passport copy), Sozialversicherungsausweis (social insurance number), Krankenversicherung membership confirmation, Steueridentifikationsnummer (tax ID), polizeiliches Führungszeugnis (criminal record extract, required for clinical and certain corporate roles), Masernimpfnachweis (measles vaccination proof for clinical staff under the Masernschutzgesetz), professional registration verification, and for non-EU nationals a residence permit or EU Blue Card with work authorisation. For clinical Helios roles, Approbation recognition (Anerkennung) by the relevant Landesbehörde is a hard prerequisite, and for foreign-qualified physicians and nurses this can take months and should be started before you apply.


Resume Tips for Fresenius SE

recommended

Lead with quantified outcomes relevant to the business you are applying to

Lead with quantified outcomes relevant to the business you are applying to. For Fresenius Kabi commercial: units shipped, sterile batches released, regulatory filings approved, biosimilar launches delivered, share-of-market, pricing-tender wins, EUR of revenue under your responsibility. For Kabi manufacturing and quality: batches manufactured, OEE, right-first-time rate, deviations closed, CAPAs implemented, regulatory inspections passed (EMA, FDA, PMDA). For Helios clinical: case volumes, DRG case mix index, mortality and complication rates benchmarked against national norms, teaching and research output, peer-reviewed publications. For corporate finance: EUR of free cash flow delivered, basis points of margin, debt reduction executed. 'Worked in pharma operations' is invisible; 'Production Manager for sterile oncology injectables at a 2.4 million-unit-per-year EU GMP site, delivered a 12 per cent OEE improvement over two years and closed two FDA inspections without critical observations' is the level of specificity Fresenius reads.

recommended

Use German professional conventions for German-based roles

Use German professional conventions for German-based roles. The Lebenslauf should be reverse-chronological with clear date ranges (MM/YYYY to MM/YYYY), a Persönliche Daten block (Geburtsdatum is optional in 2026 and many German candidates now omit it following AGG anti-discrimination practice, but date/place of birth and nationality remain common on traditional CVs), Berufserfahrung, Ausbildung, Weiterbildung, Sprachen with levels stated in Common European Framework of Reference for Languages terms (B2, C1, C2, Muttersprache), and optionally EDV-Kenntnisse and Interessen. A photograph is traditional but optional; many firms now explicitly discourage photos on AGG grounds, and Fresenius SE HR communications generally follow that modern standard.

recommended

State your Approbation and Facharzt status explicitly for any Helios clinical ph

State your Approbation and Facharzt status explicitly for any Helios clinical physician application. List the awarding state (Landesärztekammer), the date of Approbation, the Facharzt specialty and the year you earned it (for example 'Facharzt für Innere Medizin und Kardiologie, Ärztekammer Hessen, 2019'), any Zusatzbezeichnungen (for example 'Zusatzbezeichnung Notfallmedizin, 2021'), Habilitation status if applicable, and current Landesärztekammer membership. For foreign-qualified physicians, state the originating qualification, the German Anerkennung status (Kenntnisprüfung passed or Gleichwertigkeitsprüfung completed), and the Berufserlaubnis or Approbation awarding authority. Omitting this block is a dealbreaker for any physician post.

recommended

List pharma and biotech credentials precisely with dates and awarding bodies

List pharma and biotech credentials precisely with dates and awarding bodies. Diplom-Ingenieur or Master of Science in Pharmaceutical Technology, Diplom-Pharmazeut, Approbation als Apotheker, Fachapotheker für Pharmazeutische Technologie, QP status under EU GMP Annex 16 (the Qualified Person for batch release), Sachkundige Person nach AMG §14, GMP auditor qualifications (ISO 19011), Six Sigma Black Belt, Lean Manufacturing credentials, and PMP or PRINCE2 for project roles. For biopharma R&D and regulatory roles, list specific regulatory achievements (CTA, IND, BLA, MAA, 505(b)(2) filings) and clinical-development phases delivered.

recommended

For Fresenius Kabi commercial and market-access roles, lead with therapy area, g

For Fresenius Kabi commercial and market-access roles, lead with therapy area, geography, channel, and quantified outcomes. Name the product families (for example 'injectable oncology generics, anaesthesia portfolio, clinical nutrition (Kabiven, SMOFlipid, Dipeptiven), biosimilars (Stimufend, Tyenne)') and the specific tenders, accounts, and markets where you delivered. Kabi is a tender-driven and hospital-pharmacy-driven business, and named relationships with national hospital purchasing groups (Prospitalia, Sana Einkauf, Einkaufsgemeinschaft Klinikum, GPOs in the US) and with national regulatory authorities (BfArM, PEI, EMA, FDA) are meaningful signals.

recommended

For Helios Germany hospital-administration and Geschäftsführung roles, state DRG

For Helios Germany hospital-administration and Geschäftsführung roles, state DRG-system fluency, Krankenhausfinanzierungsgesetz familiarity, Medizinische Dienst (MD) audit experience, Qualitätsbericht contribution, G-BA quality-indicator performance, and experience with the Krankenhausreform under health minister Karl Lauterbach (the Krankenhausversorgungsverbesserungsgesetz / KHVVG passed in late 2024 and entering phased implementation in 2025 to 2026). These are the operating realities of running a German hospital, and demonstrated fluency is a clear differentiator over generic healthcare-administration experience.

recommended

For biopharma and biosimilar roles, be explicit about modality, platform, and de

For biopharma and biosimilar roles, be explicit about modality, platform, and development stage. CHO-cell mammalian cell culture, microbial fermentation, purification (Protein A, ion exchange, SEC), upstream and downstream process development, bioanalytics (HPLC, LC-MS, capillary electrophoresis, ELISA, cell-based potency assays), comparability studies, QbD approach, biosimilar totality-of-evidence package construction, and specific regulatory pathway experience (EU biosimilar guideline, FDA 351(k), WHO pre-qualification). Generic 'biologics experience' is vague; call out what you actually built.

recommended

For Fresenius SE corporate roles, lead with DAX-company finance and governance d

For Fresenius SE corporate roles, lead with DAX-company finance and governance depth. Group consolidation under IFRS (IAS 28 equity method for FMC is live and relevant), Deutsche Rechnungslegung (HGB) for statutory accounts, German tax residency and Organschaft structuring, Aktiengesetz and KGaA-specific governance (the firm's general partner is a management SE owned by the Else Kröner-Fresenius-Stiftung, and that governance structure has real implications for reporting lines), SEC and dual-listed-company reporting for Kabi's US footprint, Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) listed-issuer disclosure obligations, and sustainability reporting under the EU Corporate Sustainability Reporting Directive (CSRD).

recommended

Keep the CV to two pages for mid-career roles and three pages maximum for senior

Keep the CV to two pages for mid-career roles and three pages maximum for senior or clinical leadership roles with publication lists. Use a clean single-column layout in Arial, Calibri, or a similar sans-serif with 10 to 11 point body text. Avoid decorative graphics, timelines, skill bars, and multi-column layouts that the SAP SuccessFactors parser mangles. A German Lebenslauf is expected to be disciplined and conservative in style; creative-agency-style CVs are out of place.

recommended

Mirror the language of the job advert

Mirror the language of the job advert. Fresenius job postings in German use specific terminology (Sachbearbeiter, Referent, Senior Manager, Leiter, Bereichsleiter, Geschäftsführer for corporate; Assistenzarzt, Facharzt, Oberarzt, Leitender Oberarzt, Chefarzt for clinical medicine; Pflegefachfrau/-mann, Stationsleitung, Pflegedienstleitung for nursing). Use the same titles verbatim in your CV when applicable, and match the therapeutic area and product terminology of the posting. SAP SuccessFactors keyword filtering and recruiter first-sift both reward this consistency.



Interview Culture

Interviews at Fresenius are thorough, respectful, and operationally grounded.

The pace is measured, the questioning is substantive rather than theatrical, and the bar is high on technical correctness, regulatory awareness, and cultural fit with a German mid-cap industrial healthcare group mid-way through a strategic reset. Interviewers are well prepared, arrive with specific questions tied to the job specification, and expect candidates to have read the current Geschäftsbericht (annual report) and have a concrete view on Fresenius 2025, the Kabi and Helios focus, and the implications of the FMC deconsolidation for group strategy. Bluffing at senior level is quickly detected and is a hard stop. A typical experienced-hire process for a Fresenius SE corporate or Fresenius Kabi commercial, regulatory, or manufacturing role runs across three to five conversations. The first is a 30-minute recruiter screen on Microsoft Teams (or occasionally a phone call), covering motivation, salary expectations in euros, Kündigungsfrist, right-to-work, language proficiency, and high-level fit. The second is a hiring-manager competency interview, typically 45 to 60 minutes, structured around the Fresenius Leadership Principles and the specific role competencies (Kabi publishes a set of Leadership Competencies covering customer focus, accountability, collaboration, innovation, and people development that interviewers draw from). The third is a deeper technical or case-based round. For Kabi manufacturing, this is a plant-operations and quality-systems deep-dive; for regulatory, it is a walk-through of a specific filing you led; for biopharma R&D, it is a scientific presentation of a programme you contributed to; for commercial, it is a tender or market-access case; for corporate finance, it is an IFRS, cash-flow, or capital-allocation conversation. The fourth round is a panel with two or three senior leaders including a Management Board member or divisional head for senior roles. The fifth, when it occurs, is a brief meeting with a Vorstand or CFO-equivalent for group-level senior hires. For Fresenius Helios Germany clinical roles, the process is different and shaped by Kliniktradition. Physician candidates typically have an initial hospital-management HR conversation, then a Vorstellungsgespräch with the Chefarzt (department chief) of the target Klinik, sometimes followed by an Oberarzt or team-round meeting, and in senior cases a conversation with the hospital Geschäftsführer and regional Helios leadership. The Chefarzt conversation is the pivotal one and covers clinical philosophy, case-mix preference, research and teaching interest, collegial style, and whether the candidate can credibly fit into the hierarchical German hospital structure. Nursing candidates (Pflegefachfrau/-mann, Stationsleitung) go through a similar two-stage process with the ward and the Pflegedienstleitung. Interviews at Quirónsalud in Spain follow a comparable structure adjusted to Spanish conventions. Questions to expect include: 'Warum Fresenius und warum jetzt?' (Why Fresenius and why now?), 'Wie positionieren Sie sich gegenüber Baxter und B. Braun?' for Kabi commercial roles, 'Welche Erfahrung haben Sie mit FDA-Inspektionen und CAPAs?' for Kabi quality roles, 'Wie bewerten Sie die Krankenhausreform und deren Auswirkung auf Helios?' for Helios administrative roles, 'Welche Rolle sehen Sie für Biosimilars in den nächsten fünf Jahren?' for Kabi biopharma roles, 'Beschreiben Sie eine Situation, in der Sie unter Kostendruck die Qualität verteidigt haben' for operations roles, and 'Wie interpretieren Sie die FMC-Entkonsolidierung strategisch?' for senior corporate finance and strategy roles. The why-Fresenius question is taken seriously and a generic answer referencing brand size or global presence will not pass; strong answers reference a specific franchise (Kabi biosimilars, Helios Germany hospital network, Quirónsalud Spanish growth platform, group treasury and deleveraging), engage honestly with the current strategic reset, and articulate a credible personal reason beyond convenience. Dress code for final-stage corporate interviews in Bad Homburg is business attire, sober in colour and style. Kabi plant-manufacturing interviews at the factory floor sometimes shift to smart-casual because of gowning logistics, but the initial formal interview upstairs stays in business dress. Helios clinical interviews for physicians are business attire (for the formal Vorstellungsgespräch) with the understanding that a site visit may involve ward observation in clinical attire. Quirónsalud interviews in Madrid are business attire. German directness is real: interviewers will ask specific questions, expect specific answers, and will push back on weak reasoning; this is cultural, not personal.

What Fresenius SE Looks For

  • Genuine healthcare or pharmaceuticals industry experience with demonstrated operating rigour. For Kabi: sterile injectable, clinical nutrition, biosimilar, or medical-device experience at a GMP-regulated site, with documented regulatory track record. For Helios: clinical credentials (Approbation, Facharzt) plus German-hospital-system fluency, or hospital-management experience with DRG and Krankenhausplan understanding. For corporate: DAX-company or large German-industrial finance, treasury, strategy, or legal experience.
  • Regulatory and quality-system literacy. EU GMP, FDA cGMP, ICH guidelines (Q1 through Q12), EMA and FDA clinical-trial and marketing-authorisation pathways, EU MDR and IVDR for medical devices, the German Arzneimittelgesetz (AMG) and Medizinproduktegesetz / Medizinprodukterecht-Durchführungsgesetz (MPDG), and for clinical roles the German Bundesärzteordnung, Approbationsordnung, and Facharztordnung of the relevant Landesärztekammer. Regulatory knowledge is not optional in this company.
  • Quantified track record tied to operating outcomes. Batches released, OEE improvements, deviations closed, tenders won, biosimilar launches delivered, M&A integrations executed, debt reduction achieved, hospital case volumes grown, DRG case-mix index improved, peer-reviewed publications authored. Fresenius hiring managers read for operating evidence and are suspicious of abstract management prose.
  • Language capability appropriate to the role. German at C1 or above for Helios Germany clinical and administrative roles, for most Fresenius SE corporate roles based in Bad Homburg, and for Kabi German-site manufacturing and quality roles. English at C1 or above for Kabi international commercial, regulatory, biopharma R&D, and IT roles, and for Fresenius SE group finance, treasury, and investor relations. Spanish and Catalan for Quirónsalud roles in the respective regions.
  • Cultural fit with a German mid-cap industrial healthcare group owned by a charitable foundation. The Else Kröner-Fresenius-Stiftung's controlling stake creates a long-term, conservative, stakeholder-oriented ownership stance rather than a hedge-fund-driven quarterly earnings culture. Candidates who demonstrate patient, collaborative, process-disciplined behaviour and who can work effectively inside a KGaA structure with defined governance lines fare materially better than brash individualists.
  • For clinical roles at Helios Germany: demonstrable patient-care quality, collegial working style, teaching and research interest at larger Helios hospitals (Helios Klinikum Berlin-Buch, Helios Universitätsklinikum Wuppertal, Helios Klinikum Erfurt, Helios Klinikum Krefeld are among the major academic sites), and authentic engagement with the challenges facing German hospitals under cost pressure and the Lauterbach Krankenhausreform.
  • For Kabi roles: specific therapy-area or platform depth rather than generic pharma experience. Injectable oncology, anaesthesia, anti-infectives, clinical nutrition (enteral and parenteral), plasma-derived therapeutics, biosimilars (mAb platforms, fusion proteins), cell-and-gene therapy manufacturing services, or specialty medical devices for drug delivery. Depth of a specific stack outperforms breadth.
  • For corporate and group functions: German-listed-company disclosure discipline, IFRS consolidation expertise including the current equity-method treatment of FMC, capital markets communication craft under BaFin disclosure rules, and sustainability reporting depth under CSRD. Fresenius sits inside a rigorous DAX 40 disclosure regime and experienced hires are expected to operate at that standard.
  • Right to work in the European Union for EU-based roles, and credible sponsorship readiness for non-EU candidates. Fresenius sponsors EU Blue Cards and national Aufenthaltserlaubnis residence permits for specialist and shortage-list roles (notably physicians, specialist nurses, biopharma R&D scientists, senior IT, and specialist regulatory and quality roles), but sponsorship is decided case by case and is not automatic for junior or generalist positions. Foreign-qualified physicians and nurses must complete the German Anerkennung process with the relevant Landesbehörde before the clinical role can start.
  • Authentic engagement with the Fresenius 2025 strategy. Candidates who understand why FMC was deconsolidated, why Vamed was wound down, why Kabi and Helios are the two focus businesses, and what the debt-reduction and margin-recovery priorities imply for day-to-day decisions stand out from candidates who treat Fresenius as an undifferentiated large employer. Reading the most recent Geschäftsbericht and the capital markets day materials on fresenius.com is a clear and reliable investment.

Frequently Asked Questions

What ATS does Fresenius use?
SAP SuccessFactors Recruiting. The primary careers portal is careers.fresenius.com for Fresenius SE corporate and Fresenius Kabi globally. Helios Germany maintains a separately branded clinical careers portal at helios-gesundheit.de/karriere and Quirónsalud in Spain maintains quironsalud.es/trabaja-con-nosotros. All three are SAP SuccessFactors tenants but they are distinct candidate experiences with separate profiles. Create a profile in the tenant that matches the business you are targeting.
How does Fresenius pay compared to Baxter, B. Braun, and Bayer?
Compensation is competitive within German healthcare and pharma benchmarks. Fresenius Kabi commercial and manufacturing pay is broadly in line with Baxter Germany, B. Braun Melsungen, Bayer Pharmaceuticals, Boehringer Ingelheim, and Merck KGaA in Darmstadt for equivalent roles. Corporate centre pay in Bad Homburg is in line with other Frankfurt-area DAX corporates adjusted for industry. Helios Germany clinical pay is anchored by the Marburger Bund physicians' collective agreement and nursing Tarifverträge and is therefore comparable to Sana Kliniken, Asklepios, and the major municipal hospital operators. A long-term incentive plan in Fresenius SE shares (ETR:FRE) applies to senior roles. Negotiation on base is real for non-tariff positions; tariff-bound clinical roles leave less room for individual negotiation at junior and mid levels.
Where are Fresenius's main offices and sites?
The group corporate centre is at Else-Kröner-Straße 1 in Bad Homburg vor der Höhe, Hesse, Germany. Fresenius Kabi's headquarters and a major manufacturing and R&D footprint are in Bad Homburg and Friedberg in the wider Rhein-Main region, with further significant sites in Oberursel, Schweinfurt, Halle (Westfalen), and numerous international sites across Graz in Austria, Lake Zurich in the United States, Melsungen-adjacent Germany, Kriens in Switzerland, and a large Indian operation. Fresenius Helios operates approximately 87 hospitals across Germany from smaller community Kliniken through to major academic hospitals including Helios Klinikum Berlin-Buch, Helios Universitätsklinikum Wuppertal, Helios Klinikum Erfurt, and Helios Klinikum Krefeld, among others. Quirónsalud operates from Madrid and runs approximately 57 hospitals and a large outpatient network across Spain, most concentrated in Madrid, Catalonia, Andalusia, Valencia, and the Balearic Islands. Hybrid working is available in many corporate roles at Bad Homburg and Kabi administrative sites, typically two to three days in the office per week; clinical roles at Helios hospitals and manufacturing roles at Kabi plants are onsite by nature.
Does Fresenius sponsor work visas and EU Blue Cards?
Yes, for specific roles. Fresenius sponsors EU Blue Cards (under the EU Directive 2009/50/EC as implemented in the German Aufenthaltsgesetz) and national Aufenthaltserlaubnis residence permits for specialist and shortage-list roles including physicians, specialist nurses, specialist pharma scientists, senior IT roles, and specialist regulatory and quality roles. Sponsorship is decided role by role and is not automatic for junior or generalist positions. Foreign-qualified physicians and nurses must complete the Anerkennung (professional qualification recognition) process with the relevant Landesbehörde before a clinical role can start; this process typically takes several months and should be initiated well before the application. Quirónsalud in Spain operates under Spanish work-permit and Spanish medical-registration rules. For Kabi US, Kabi India, and Kabi Austria roles, local immigration rules and locally adapted sponsorship policies apply.
Does Fresenius run apprenticeship and dual-study programmes?
Yes. Fresenius Kabi runs several Ausbildung tracks aligned to IHK curricula including Pharmakant (pharmaceutical process operator), Chemielaborant (chemistry lab technician), Mechatroniker, Elektroniker für Betriebstechnik, Industriekaufmann/-frau (industrial business clerk), and Fachinformatiker (IT specialist) with three-year structured programmes combining workplace training and vocational school. Helios Germany runs Ausbildung tracks for Pflegefachfrau/-mann (generalist nursing under the 2020 reform), Medizinische Fachangestellte (MFA), Anästhesietechnische Assistenz (ATA), Operationstechnische Assistenz (OTA), Notfallsanitäter (paramedic), and Kauffrau/-mann im Gesundheitswesen (healthcare business administration). Dual-study (duales Studium) partnerships cover business administration, nursing management, and technical fields through Duale Hochschulen and partner universities. Application windows typically open in autumn for a start date the following summer. Check the current year's windows on careers.fresenius.com and helios-gesundheit.de/karriere.
What happened with Fresenius Medical Care and why was it deconsolidated?
Fresenius Medical Care AG (ETR:FME) is the dialysis business and was historically the largest subsidiary of Fresenius SE. In late 2023, following a shareholder-approved change in FMC's legal form from KGaA to AG, Fresenius SE's ability to exercise control over FMC operations was reduced in a way that required FMC to be reclassified from full consolidation to the equity method (IAS 28) in the Fresenius SE group accounts. FMC remains a separately listed DAX-constituent company in which Fresenius SE continues to hold a significant minority stake (in the region of 32 to 33 per cent historically, subject to ongoing portfolio decisions), but FMC revenue, costs, and headcount are no longer consolidated line-by-line into Fresenius SE group totals. Candidates applying to Fresenius SE or Fresenius Kabi will not be joining FMC; FMC runs its own careers portal, its own strategy, and its own CEO and Management Board separately from Fresenius SE.
What is Fresenius Helios and how does it compare to Sana Kliniken and Asklepios?
Fresenius Helios is the largest private hospital operator in Europe, running approximately 87 hospitals in Germany under the Helios Kliniken brand (Helios Gesundheit) and approximately 57 hospitals plus a large outpatient and diagnostics network in Spain under the Quirónsalud brand acquired in 2017. In Germany, Helios competes directly with Sana Kliniken, Asklepios Kliniken (which absorbed Rhön-Klinikum substantially), and with the university and municipal (kommunal) hospital sectors. Helios Germany operates under the Gemeinsamer Bundesausschuss (G-BA) quality regime, state-level Krankenhausplan hospital planning, the DRG reimbursement system, and Gesetzliche Krankenversicherung (GKV) and private insurance pay channels. The Lauterbach-era Krankenhausreform (Krankenhausversorgungsverbesserungsgesetz, KHVVG) passed in late 2024 and entering phased implementation in 2025 to 2026 is reshaping the German hospital landscape and is a central topic for any Helios administrative or medical leadership interview.
What does Fresenius Kabi actually do and how does it compare to Baxter and B. Braun?
Fresenius Kabi is a global specialty pharmaceuticals and medical-nutrition business operating in more than 100 countries. Its portfolio spans intravenous generics (injectable oncology, anaesthesia, anti-infectives, critical-care medicines), clinical nutrition (enteral nutrition, parenteral nutrition including products like Kabiven, SMOFlipid, and Dipeptiven, plus compounding services for hospital pharmacies), medical devices for drug delivery and infusion therapy, plasma-derived therapeutics (following the Ivenix and biopharma footprint evolution), and a growing biopharmaceuticals franchise including the biosimilars Stimufend (pegfilgrastim) and Tyenne (tocilizumab), cell-and-gene therapy manufacturing services, and continuing pipeline development. Direct peers are Baxter International (clinical nutrition, IV solutions, medical devices), B. Braun Melsungen (infusion therapy, IV drugs, medical devices, hospital supply), Hospira-Pfizer Injectables, Nipro Corporation in Japan, and Otsuka for clinical nutrition. In biosimilars specifically, peers are Sandoz (Novartis biosimilars), Celltrion, and Samsung Bioepis.
How long does the Fresenius hiring process take?
Typically six to twelve weeks from CV submission to verbal offer for experienced-hire corporate and Kabi roles, then a further three to six weeks for written offer, reference collection, and pre-employment documentation (polizeiliches Führungszeugnis, Masernimpfnachweis for clinical staff, Approbation recognition for foreign-qualified physicians, and visa or Blue Card processing where relevant). Helios clinical hires can run longer, particularly for Chefarzt and senior Oberarzt roles where multi-stage interviews, departmental committee reviews, and board-level approval all apply. Ausbildung and dual-study applications follow a fixed annual timetable, typically running from autumn application opening to the following summer's start date.
What is the dress code for a Fresenius interview?
Business attire (Anzug und Krawatte or business equivalent) for any final-stage corporate interview at Bad Homburg, for Kabi commercial interviews, for Helios physician Vorstellungsgespräche, and for Quirónsalud head-office interviews in Madrid. Kabi manufacturing interviews at factory sites may shift to smart-casual for the plant-floor tour because of gowning logistics. Helios site visits for physician candidates may include ward observation in clinical attire after the initial formal conversation. Quirónsalud interviews in Spain generally track the same formality as Bad Homburg for the formal stages. When uncertain, default to business attire.
Is German required at Fresenius?
For Helios Germany clinical roles (physicians, nurses, therapists, MTA, pharmacists, ward clerks) and Helios Germany hospital-administration roles, yes, effectively at C1 or above. Patient care in Germany requires fluent German for patient communication, clinical documentation, colleague coordination, and regulatory compliance under the Approbationsordnung and the relevant Bundesärzteordnung and nursing regulations. For most Fresenius SE corporate roles based in Bad Homburg, German is the day-to-day working language and C1 or above is a practical requirement, though selected group functions (treasury, investor relations, international strategy) operate substantially in English. For Fresenius Kabi international commercial, regulatory, biopharma R&D, and IT roles, English at C1 or above is the primary working language and German is a welcome plus rather than a hard requirement. For Quirónsalud clinical and administrative roles in Spain, Spanish at C1 or above is required, with Catalan also required for Catalonia-based positions.
Can I move between Fresenius SE, Kabi, Helios, and Quirónsalud internally?
Internal mobility exists but is structured by business. Mobility between Fresenius SE corporate centre and Fresenius Kabi is relatively straightforward because the two share the careers.fresenius.com SuccessFactors tenant and a common HR function with a unified talent-management system. Mobility between Kabi or Fresenius SE corporate and Helios Germany is less frequent because Helios runs a largely self-contained clinical and hospital-management talent system with site- and region-level recruiting. Mobility between Helios Germany and Quirónsalud in Spain is possible for senior medical and management roles but requires Spanish language and Spanish regulatory adaptation. International mobility within Kabi across Germany, Austria, the United States, and India is well supported for specialist and leadership roles, and the group runs structured expatriate and international-assignment frameworks with tax-equalisation and relocation support.
How do Bad Homburg, Friedberg, and the Kabi international sites differ?
Bad Homburg vor der Höhe hosts the Fresenius SE corporate centre and the Fresenius Kabi headquarters and is the natural home for group finance, treasury, investor relations, legal, communications, group strategy, group HR, and Kabi senior commercial and corporate functions. Friedberg in Hesse is a major Kabi manufacturing and R&D site with substantial engineering, quality, production, and supply-chain headcount. Kabi's Austrian operation (historically anchored around Graz) supports parenteral nutrition, Kabi US (including Lake Zurich, Illinois) supports North American manufacturing and commercial operations, and Kabi India supports manufacturing and global capability centres. Each site has its own rhythm: Bad Homburg is corporate and group-oriented; Friedberg is manufacturing-led; the international Kabi sites are a mix of manufacturing, commercial, and development depending on location.
What is 'Fresenius 2025' and why does it matter for candidates?
Fresenius 2025 is the strategic programme launched by CEO Michael Sen after he took over on 1 October 2022. Its stated aims are to simplify the group portfolio (including the deconsolidation of FMC in 2023 and the wind-down of Vamed), to focus on Kabi and Helios as the two operating businesses, to restore operating margins at Kabi through commercial and manufacturing improvements and biosimilar growth, to grow Helios organically in Germany and Spain, to reduce group net debt to a more conservative level, and to run a slimmer, more disciplined corporate centre. It matters for candidates because it is the real operating context of the company in 2026: hiring priorities, cost discipline, capital allocation, and leadership attention are all organised around this plan. Candidates who have read the most recent Geschäftsbericht (annual report), the capital markets day materials, and recent Reuters, Bloomberg, and Financial Times coverage of the plan arrive visibly better prepared and fare materially better at senior interviews.
How does the FCA-equivalent German regulatory environment affect roles at Fresenius?
Fresenius SE is listed on the Frankfurt Stock Exchange and regulated for disclosure purposes by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) under the Wertpapierhandelsgesetz (WpHG) and the EU Market Abuse Regulation. Fresenius Kabi's pharma operations are regulated by the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) and the Paul-Ehrlich-Institut (PEI) in Germany, the European Medicines Agency for centralised procedures, the US FDA for US market access, and dozens of national authorities globally. Helios Germany hospitals are regulated by the Gemeinsamer Bundesausschuss (G-BA) on quality, by state-level Landesbehörden on hospital planning and operational licensing, by the Medizinische Dienst (MD) on audit, and sit inside the GKV statutory health insurance and DRG payment frameworks. Quirónsalud operates inside the Spanish Sistema Nacional de Salud framework and the Seguridad Social payment system alongside private and insurer-pay channels. Authentic understanding of the relevant regulatory context is a clear differentiator in interviews for any non-junior role.

Open Positions

Fresenius SE currently has 4 open positions.

Check Your Resume Before Applying → View 4 open positions at Fresenius SE

Related Resources

Similar Companies

Related Articles


Sources

  1. Fresenius SE Corporate Website
  2. Fresenius Careers (SAP SuccessFactors)
  3. Fresenius Kabi Global Website
  4. Helios Gesundheit (Helios Germany)
  5. Quirónsalud Careers (Spain)
  6. Fresenius Management Board and CEO Michael Sen
  7. Reuters: Fresenius CEO Sen and Fresenius 2025 Strategy Coverage
  8. Financial Times: Fresenius Restructuring and FMC Deconsolidation Coverage
  9. Bloomberg: Fresenius SE (FRE GR) Company Profile
  10. Deutsche Börse DAX 40 Constituents
  11. Deutsches Ärzteblatt (Bundesärztekammer)
  12. Bundesärztekammer (German Medical Association)
  13. Gemeinsamer Bundesausschuss (G-BA)
  14. Marburger Bund (Physicians' Collective Bargaining)
  15. Glassdoor Germany: Fresenius Reviews